Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cvs Health Corp (CVS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cvs Health Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 64803.
Total stock buying since 2015: $8,457,750.
Total stock sales since 2015: $689,861,858.
Total stock option exercises since 2015: $243,920,692.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 31,570 | $2,101,009 | 3,765,013 | $256,489,260 | 8,359 | $520,012 |
| 2024 | 10,181 | $554,170 | 29,473 | $2,267,947 | 0 | $0 |
| 2023 | 16,000 | $1,117,499 | 25,759 | $1,928,447 | 0 | $0 |
| 2022 | 1,000 | $105,904 | 523,728 | $52,862,219 | 500,936 | $36,204,285 |
| 2021 | 6,000 | $454,635 | 1,210,883 | $97,342,921 | 1,177,451 | $76,470,761 |
| 2020 | 5,000 | $315,675 | 372,727 | $27,403,100 | 408,047 | $21,830,828 |
| 2019 | 30,910 | $1,677,085 | 541,619 | $36,585,546 | 462,198 | $21,305,764 |
| 2018 | 34,300 | $2,131,773 | 107,188 | $8,347,257 | 63,662 | $3,054,839 |
| 2017 | 0 | $0 | 1,294,535 | $104,248,948 | 1,119,034 | $44,509,463 |
| 2016 | 0 | $0 | 181,869 | $17,977,781 | 162,753 | $5,493,012 |
| 2015 | 0 | $0 | 862,348 | $84,408,432 | 795,120 | $34,531,728 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 7,500 | $532,650 | 0 | $0 |
| 2025-06 | 1,570 | $100,009 | 0 | $0 | 0 | $0 |
| 2025-05 | 0 | $0 | 3,750,000 | $255,458,123 | 0 | $0 |
| 2025-03 | 0 | $0 | 7,513 | $498,487 | 8,359 | $520,012 |
| 2025-02 | 30,000 | $2,001,000 | 0 | $0 | 0 | $0 |
| 2024-05 | 10,181 | $554,170 | 0 | $0 | 0 | $0 |
| 2024-02 | 0 | $0 | 29,473 | $2,267,947 | 0 | $0 |
| 2023-11 | 2,000 | $140,930 | 0 | $0 | 0 | $0 |
| 2023-08 | 0 | $0 | 25,759 | $1,928,447 | 0 | $0 |
| 2023-05 | 14,000 | $976,569 | 0 | $0 | 0 | $0 |
| 2022-08 | 0 | $0 | 152,986 | $15,146,966 | 152,986 | $8,704,581 |
| 2022-06 | 0 | $0 | 138,654 | $13,172,130 | 138,654 | $8,635,371 |
| 2022-04 | 0 | $0 | 78,254 | $7,917,366 | 57,151 | $3,298,475 |
| 2022-03 | 0 | $0 | 9,970 | $1,052,875 | 8,281 | $854,327 |
| 2022-02 | 1,000 | $105,904 | 69,323 | $7,550,636 | 69,323 | $7,088,969 |
| 2022-01 | 0 | $0 | 74,541 | $8,022,246 | 74,541 | $7,622,562 |
| 2021-11 | 0 | $0 | 137,029 | $12,876,960 | 137,029 | $6,643,195 |
| 2021-10 | 0 | $0 | 82,757 | $7,282,616 | 80,802 | $4,378,660 |
| 2021-09 | 0 | $0 | 2,625 | $228,375 | 0 | $0 |
| 2021-08 | 3,000 | $238,635 | 0 | $0 | 0 | $0 |
| 2021-06 | 0 | $0 | 107,927 | $9,297,798 | 98,001 | $5,837,435 |
| 2021-05 | 0 | $0 | 123,851 | $10,602,802 | 158,748 | $9,685,002 |
| 2021-04 | 0 | $0 | 103,423 | $7,963,571 | 101,003 | $5,473,352 |
| 2021-03 | 0 | $0 | 480,469 | $35,954,509 | 431,955 | $32,089,934 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-20 | Finucane Anne A. (Director) | Sale | 7,500 | 71.02 | 532,650 |
| 2025-06-05 | Sansone Guy P (Director) | Buy | 1,570 | 63.70 | 100,009 |
| 2025-05-06 | Robbins Larry | Sale | 150,000 | 66.67 | 10,000,650 |
| 2025-05-05 | Robbins Larry | Sale | 1,323,932 | 67.68 | 89,603,717 |
| 2025-05-02 | Robbins Larry | Sale | 2,276,068 | 68.47 | 155,853,756 |
| 2025-03-17 | Shah Prem S (EVP and Group President) | Option Ex | 846 | 62.21 | 52,629 |
| 2025-03-05 | Clark James David (SVP, Cont & Chief Acct Officer) | Sale | 7,513 | 66.35 | 498,487 |
| 2025-03-05 | Clark James David (SVP, Cont & Chief Acct Officer) | Option Ex | 7,513 | 62.21 | 467,383 |
| 2025-02-18 | Mahoney Michael F (Director) | Buy | 30,000 | 66.70 | 2,001,000 |
| 2024-05-02 | Mahoney Michael F (Director) | Buy | 9,181 | 54.49 | 500,291 |
| 2024-05-02 | Ludwig Edward J (Director) | Buy | 1,000 | 53.88 | 53,879 |
| 2024-02-16 | Shah Prem S (EVP and Pres-Pharm, Consumer W) | Sale | 29,473 | 76.95 | 2,267,947 |
| 2023-11-03 | Ludwig Edward J (Director) | Buy | 2,000 | 70.47 | 140,930 |
| 2023-08-03 | Clark James David (SVP, Cont & Chief Acct Officer) | Sale | 25,759 | 74.86 | 1,928,447 |
| 2023-05-03 | Lynch Karen S (President and CEO) | Buy | 14,000 | 69.75 | 976,569 |
| 2022-08-04 | Lotvin Alan (EVP&President-PharmacyServices) | Sale | 22,541 | 104.00 | 2,344,264 |
| 2022-08-04 | Lotvin Alan (EVP&President-PharmacyServices) | Option Ex | 22,541 | 62.21 | 1,402,275 |
| 2022-08-03 | Finke Daniel P (EVP/Pres, Health Care Benefits) | Sale | 9,546 | 100.00 | 954,600 |
| 2022-08-03 | Finke Daniel P (EVP/Pres, Health Care Benefits) | Option Ex | 9,546 | 52.37 | 499,924 |
| 2022-08-03 | Lotvin Alan (EVP&President-PharmacyServices) | Sale | 120,899 | 98.00 | 11,848,102 |
| 2022-08-03 | Lotvin Alan (EVP&President-PharmacyServices) | Option Ex | 120,899 | 56.27 | 6,802,382 |
| 2022-06-28 | Moriarty Thomas M (EVP & General Counsel) | Sale | 138,654 | 95.00 | 13,172,130 |
| 2022-06-28 | Moriarty Thomas M (EVP & General Counsel) | Option Ex | 138,654 | 62.28 | 8,635,371 |
| 2022-04-08 | Shah Prem S (EVP and Co-President of Retail) | Sale | 16,954 | 105.00 | 1,780,170 |
| 2022-04-08 | Shah Prem S (EVP and Co-President of Retail) | Option Ex | 13,824 | 62.26 | 860,682 |
| 2022-04-05 | Finke Daniel P (EVP/Pres, Health Care Benefits) | Sale | 5,941 | 100.00 | 594,100 |
| 2022-04-04 | Finke Daniel P (EVP/Pres, Health Care Benefits) | Sale | 55,359 | 100.13 | 5,543,096 |
| 2022-04-04 | Finke Daniel P (EVP/Pres, Health Care Benefits) | Option Ex | 43,327 | 56.27 | 2,437,793 |
| 2022-03-30 | Shah Prem S (EVP and Co-President of Retail) | Sale | 5,346 | 104.70 | 559,726 |
| 2022-03-30 | Shah Prem S (EVP and Co-President of Retail) | Option Ex | 5,346 | 102.26 | 546,681 |
| 2022-03-17 | Shah Prem S (EVP and Co-President of Retail) | Sale | 4,624 | 106.65 | 493,149 |
| 2022-03-17 | Shah Prem S (EVP and Co-President of Retail) | Option Ex | 2,935 | 104.82 | 307,646 |
| 2022-02-10 | Ludwig Edward J (Director) | Buy | 1,000 | 105.90 | 105,904 |
| 2022-02-03 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 47,937 | 110.00 | 5,273,070 |
| 2022-02-03 | Brennan Troyen A (EVP and Chief Medical Officer) | Option Ex | 47,937 | 102.26 | 4,902,037 |
| 2022-02-01 | Lotvin Alan (EVP&President-PharmacyServices) | Sale | 21,386 | 106.50 | 2,277,566 |
| 2022-02-01 | Lotvin Alan (EVP&President-PharmacyServices) | Option Ex | 21,386 | 102.26 | 2,186,932 |
| 2022-01-28 | Clark James David (SVP, Cont & Chief Acct Officer) | Sale | 6,059 | 109.00 | 660,431 |
| 2022-01-28 | Clark James David (SVP, Cont & Chief Acct Officer) | Option Ex | 6,059 | 102.26 | 619,593 |
| 2022-01-27 | Roberts Jonathan C (EVP & Chief Operating Officer) | Sale | 68,482 | 107.50 | 7,361,815 |
| 2022-01-27 | Roberts Jonathan C (EVP & Chief Operating Officer) | Option Ex | 68,482 | 102.26 | 7,002,969 |
| 2021-11-03 | Roberts Jonathan C (EVP & Chief Operating Officer) | Sale | 108,870 | 95.00 | 10,342,650 |
| 2021-11-03 | Roberts Jonathan C (EVP & Chief Operating Officer) | Option Ex | 108,870 | 45.93 | 5,000,399 |
| 2021-11-01 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 28,159 | 90.00 | 2,534,310 |
| 2021-11-01 | Brennan Troyen A (EVP and Chief Medical Officer) | Option Ex | 28,159 | 58.34 | 1,642,796 |
| 2021-10-26 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 82,757 | 88.00 | 7,282,616 |
| 2021-10-26 | Brennan Troyen A (EVP and Chief Medical Officer) | Option Ex | 80,802 | 54.19 | 4,378,660 |
| 2021-09-02 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 2,625 | 87.00 | 228,375 |
| 2021-08-05 | Ludwig Edward J (Director) | Buy | 3,000 | 79.55 | 238,635 |
| 2021-06-28 | Lotvin Alan (EVP&President-PharmacyServices) | Sale | 2,781 | 83.67 | 232,686 |
| 2021-06-15 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 67,552 | 86.00 | 5,809,472 |
| 2021-06-15 | Brennan Troyen A (EVP and Chief Medical Officer) | Option Ex | 65,681 | 62.21 | 4,086,015 |
| 2021-06-07 | Finke Daniel P (EVP/Pres, Health Care Benefits) | Sale | 37,594 | 86.60 | 3,255,640 |
| 2021-06-07 | Finke Daniel P (EVP/Pres, Health Care Benefits) | Option Ex | 32,320 | 54.19 | 1,751,420 |
| 2021-05-10 | Moriarty Thomas M (EVP & General Counsel) | Sale | 109,469 | 86.00 | 9,414,334 |
| 2021-05-10 | Moriarty Thomas M (EVP & General Counsel) | Option Ex | 109,469 | 62.21 | 6,810,066 |
| 2021-05-07 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 9,477 | 84.00 | 796,068 |
| 2021-05-04 | Boratto Eva C (EVP & CFO) | Sale | 4,905 | 80.00 | 392,400 |
| 2021-05-04 | Moriarty Thomas M (EVP & General Counsel) | Option Ex | 49,279 | 58.34 | 2,874,936 |
| 2021-04-21 | Moriarty Thomas M (EVP & General Counsel) | Sale | 103,423 | 77.00 | 7,963,571 |
| 2021-04-21 | Moriarty Thomas M (EVP & General Counsel) | Option Ex | 101,003 | 54.19 | 5,473,352 |
| 2021-03-31 | Clark James David (SVP, Cont & Chief Acct Officer) | Sale | 5,350 | 76.00 | 406,600 |
| 2021-03-31 | Clark James David (SVP, Cont & Chief Acct Officer) | Option Ex | 5,350 | 74.29 | 397,451 |
| 2021-03-29 | Moriarty Thomas M (EVP & General Counsel) | Sale | 62,943 | 76.15 | 4,793,109 |
| 2021-03-29 | Moriarty Thomas M (EVP & General Counsel) | Option Ex | 62,943 | 74.29 | 4,676,035 |
| 2021-03-26 | Roberts Jonathan C (EVP & Chief Operating Officer) | Sale | 73,433 | 74.49 | 5,470,024 |
| 2021-03-26 | Roberts Jonathan C (EVP & Chief Operating Officer) | Option Ex | 73,433 | 74.29 | 5,455,337 |
| 2021-03-26 | Merlo Larry J (Director) | Sale | 270,650 | 74.73 | 20,225,674 |
| 2021-03-26 | Merlo Larry J (Director) | Option Ex | 271,347 | 74.29 | 20,158,368 |
| 2021-03-19 | Moriarty Thomas M (EVP & General Counsel) | Sale | 49,211 | 74.15 | 3,648,995 |
| 2021-03-16 | Boratto Eva C (EVP & CFO) | Sale | 18,882 | 74.68 | 1,410,107 |
| 2021-03-16 | Boratto Eva C (EVP & CFO) | Option Ex | 18,882 | 74.29 | 1,402,743 |
| 2021-02-17 | Ludwig Edward J (Director) | Buy | 3,000 | 72.00 | 216,000 |
| 2021-01-19 | Merlo Larry J (President and CEO) | Sale | 62,893 | 77.00 | 4,842,761 |
| 2021-01-19 | Merlo Larry J (President and CEO) | Option Ex | 64,350 | 74.29 | 4,780,561 |
| 2021-01-12 | Bisaccia Lisa (EVP and Chief HR Officer) | Sale | 25,177 | 77.00 | 1,938,629 |
| 2021-01-12 | Bisaccia Lisa (EVP and Chief HR Officer) | Option Ex | 25,177 | 74.29 | 1,870,399 |
| 2021-01-08 | Lotvin Alan (EVP and President-CVS Caremark) | Sale | 25,836 | 75.00 | 1,937,700 |
| 2021-01-08 | Lotvin Alan (EVP and President-CVS Caremark) | Option Ex | 25,836 | 64.24 | 1,659,704 |
| 2021-01-08 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 58,896 | 75.00 | 4,417,200 |
| 2021-01-08 | Brennan Troyen A (EVP and Chief Medical Officer) | Option Ex | 54,550 | 74.29 | 4,052,519 |
| 2020-11-13 | Lotvin Alan (EVP and President-CVS Caremark) | Sale | 7,138 | 70.00 | 499,660 |
| 2020-11-10 | Flum Joshua Matthew (EVP, ENT STRATEGY & DIGITAL) | Sale | 21,460 | 70.00 | 1,502,200 |
| 2020-11-10 | Flum Joshua Matthew (EVP, ENT STRATEGY & DIGITAL) | Option Ex | 21,460 | 34.96 | 750,241 |
| 2020-05-26 | Mayhew Jonathan E. (EVP - Transformation) | Sale | 10,556 | 65.00 | 686,140 |
| 2020-05-26 | Clark James David (SVP, Cont & Chief Acct Officer) | Sale | 270 | 65.00 | 17,550 |
| 2020-05-11 | Lotvin Alan (EVP and President-CVS Caremark) | Buy | 5,000 | 63.13 | 315,675 |
| 2020-04-28 | Clark James David (SVP, Cont & Chief Acct Officer) | Sale | 6,234 | 65.00 | 405,210 |
| 2020-03-30 | Clark James David (SVP, Cont & Chief Acct Officer) | Sale | 3,030 | 60.00 | 181,800 |
| 2020-03-30 | Clark James David (SVP, Cont & Chief Acct Officer) | Option Ex | 3,030 | 54.53 | 165,225 |
| 2020-01-15 | Merlo Larry J (President and CEO) | Sale | 266,476 | 74.79 | 19,929,740 |
| 2020-01-15 | Merlo Larry J (President and CEO) | Option Ex | 314,713 | 54.53 | 17,161,299 |
| 2020-01-08 | Roberts Jonathan C (EVP & Chief Operating Officer) | Sale | 57,563 | 72.63 | 4,180,800 |
| 2020-01-08 | Roberts Jonathan C (EVP & Chief Operating Officer) | Option Ex | 68,844 | 54.53 | 3,754,063 |
| 2019-11-18 | Lynch Karen S (EVP & Pres, Aetna Bus Unit) | Sale | 80,143 | 75.00 | 6,010,725 |
| 2019-11-04 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 23,604 | 68.00 | 1,605,072 |
| 2019-11-04 | Brennan Troyen A (EVP and Chief Medical Officer) | Option Ex | 23,604 | 54.53 | 1,287,126 |
| 2019-09-30 | Flum Joshua Matthew (EVP, ENT STRATEGY & DIGITAL) | Sale | 17,703 | 63.00 | 1,115,289 |
| 2019-09-30 | Flum Joshua Matthew (EVP, ENT STRATEGY & DIGITAL) | Option Ex | 17,703 | 54.53 | 965,344 |
| 2019-09-12 | Boratto Eva C (EVP & CFO) | Sale | 8,130 | 65.00 | 528,450 |
| 2019-09-12 | Boratto Eva C (EVP & CFO) | Option Ex | 8,852 | 54.53 | 482,699 |
| 2019-03-11 | Aguirre Fernando (Director) | Buy | 1,900 | 53.59 | 101,821 |
| 2019-03-11 | Brown C David Ii (Director) | Buy | 10,000 | 53.18 | 531,800 |
| 2019-03-08 | Ludwig Edward J (Director) | Buy | 2,000 | 52.80 | 105,600 |
| 2019-03-08 | Dorman David W (Director) | Buy | 9,600 | 52.71 | 506,016 |
| 2019-03-01 | Clark James David (SVP, Cont & Chief Acct Officer) | Sale | 1,664 | 58.14 | 96,744 |
| 2019-03-01 | Clark James David (SVP, Cont & Chief Acct Officer) | Option Ex | 1,664 | 45.07 | 74,996 |
| 2019-03-01 | Aguirre Fernando (Director) | Buy | 3,410 | 58.29 | 198,768 |
| 2019-03-01 | Ludwig Edward J (Director) | Buy | 4,000 | 58.27 | 233,080 |
| 2019-02-01 | Roberts Jonathan C (EVP & Chief Operating Officer) | Sale | 77,639 | 64.54 | 5,010,821 |
| 2019-02-01 | Roberts Jonathan C (EVP & Chief Operating Officer) | Option Ex | 77,639 | 45.07 | 3,499,189 |
| 2019-02-01 | Merlo Larry J (President and CEO) | Sale | 166,368 | 64.51 | 10,732,399 |
| 2019-02-01 | Merlo Larry J (President and CEO) | Option Ex | 166,368 | 45.07 | 7,498,205 |
| 2019-01-08 | Merlo Larry J (President and CEO) | Sale | 166,368 | 69.04 | 11,486,046 |
| 2019-01-08 | Merlo Larry J (President and CEO) | Option Ex | 166,368 | 45.07 | 7,498,205 |
| 2018-11-29 | Denton David M (EVP and CFO) | Sale | 25,159 | 80.13 | 2,015,990 |
| 2018-11-14 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 14,229 | 82.00 | 1,166,778 |
| 2018-10-01 | Boratto Eva C (EVP, Cont & Chief Acct Officer) | Sale | 4,426 | 80.00 | 354,080 |
| 2018-10-01 | Boratto Eva C (EVP, Cont & Chief Acct Officer) | Option Ex | 4,426 | 54.53 | 241,349 |
| 2018-10-01 | Bisaccia Lisa (EVP and Chief HR Officer) | Sale | 21,534 | 80.00 | 1,722,720 |
| 2018-10-01 | Bisaccia Lisa (EVP and Chief HR Officer) | Option Ex | 21,534 | 49.80 | 1,072,393 |
| 2018-09-17 | Boratto Eva C (EVP, Cont & Chief Acct Officer) | Sale | 13,311 | 77.16 | 1,027,076 |
| 2018-09-17 | Boratto Eva C (EVP, Cont & Chief Acct Officer) | Option Ex | 13,311 | 45.07 | 599,926 |
| 2018-08-27 | Hourican Kevin (EVP & President, CVS Pharmacy) | Sale | 8,564 | 75.00 | 642,300 |
| 2018-08-27 | Hourican Kevin (EVP & President, CVS Pharmacy) | Option Ex | 4,426 | 54.53 | 241,349 |
| 2018-05-04 | Brown C David Ii (Director) | Buy | 10,000 | 61.99 | 619,900 |
| 2018-05-04 | Dorman David W (Director) | Buy | 24,300 | 62.22 | 1,511,873 |
| 2018-02-16 | Foulkes Helena (EVP & President-CVS Pharmacy) | Sale | 19,965 | 71.04 | 1,418,313 |
| 2018-02-16 | Foulkes Helena (EVP & President-CVS Pharmacy) | Option Ex | 19,965 | 45.07 | 899,822 |
| 2017-12-21 | Bisaccia Lisa (EVP and Chief HR Officer) | Sale | 29,445 | 75.00 | 2,208,375 |
| 2017-10-02 | Moriarty Thomas M (EVP & General Counsel) | Sale | 20,547 | 81.17 | 1,667,779 |
| 2017-10-02 | Moriarty Thomas M (EVP & General Counsel) | Option Ex | 20,547 | .00 | 0 |
| 2017-09-18 | Roberts Jonathan C (EVP & Chief Operating Officer) | Sale | 85,743 | 83.14 | 7,128,673 |
| 2017-09-18 | Roberts Jonathan C (EVP & Chief Operating Officer) | Option Ex | 85,743 | 34.96 | 2,997,575 |
| 2017-09-15 | Foulkes Helena (EVP & President-CVS Pharmacy) | Sale | 39,340 | 81.88 | 3,221,159 |
| 2017-09-15 | Foulkes Helena (EVP & President-CVS Pharmacy) | Option Ex | 39,340 | 54.53 | 2,145,210 |
| 2017-09-13 | Merlo Larry J (President and CEO) | Sale | 241,150 | 83.07 | 20,032,330 |
| 2017-09-13 | Merlo Larry J (President and CEO) | Option Ex | 241,150 | 34.96 | 8,430,604 |
| 2017-09-11 | Denton David M (EVP and CFO) | Sale | 237,078 | 79.64 | 18,880,180 |
| 2017-09-11 | Denton David M (EVP and CFO) | Option Ex | 108,183 | 54.53 | 5,899,218 |
| 2017-09-11 | Moriarty Thomas M (EVP & General Counsel) | Sale | 90,267 | 79.61 | 7,186,155 |
| 2017-09-11 | Moriarty Thomas M (EVP & General Counsel) | Option Ex | 90,267 | 51.60 | 4,657,777 |
| 2017-08-16 | Swift Richard J (Director) | Sale | 2,500 | 79.62 | 199,050 |
| 2017-06-26 | Foulkes Helena (EVP, President-CVS Pharmacy) | Sale | 20,333 | 80.00 | 1,626,640 |
| 2017-06-26 | Foulkes Helena (EVP, President-CVS Pharmacy) | Option Ex | 20,333 | 34.96 | 710,841 |
| 2017-06-19 | Foulkes Helena (EVP, President-CVS Pharmacy) | Sale | 20,332 | 76.98 | 1,565,157 |
| 2017-06-19 | Foulkes Helena (EVP, President-CVS Pharmacy) | Option Ex | 20,332 | 34.96 | 710,806 |
| 2017-06-12 | Denton David M (EVP and CFO) | Sale | 230,510 | 80.00 | 18,440,800 |
| 2017-06-12 | Denton David M (EVP and CFO) | Option Ex | 230,510 | 40.10 | 9,244,142 |
| 2017-03-21 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 23,849 | 78.73 | 1,877,631 |
| 2017-03-21 | Brennan Troyen A (EVP and Chief Medical Officer) | Option Ex | 16,637 | 45.07 | 749,829 |
| 2017-03-17 | Boratto Eva C (EVP, Cont & Chief Acct Officer) | Sale | 6,029 | 79.60 | 479,908 |
| 2017-03-17 | Boratto Eva C (EVP, Cont & Chief Acct Officer) | Option Ex | 6,029 | 34.96 | 210,773 |
| 2017-03-13 | Sussman Andrew (EVP, Clinical Services) | Sale | 14,104 | 80.40 | 1,133,961 |
| 2017-03-13 | Sussman Andrew (EVP, Clinical Services) | Option Ex | 6,655 | 45.07 | 299,940 |
| 2017-03-10 | Denton David M (EVP and CFO) | Sale | 95,618 | 80.68 | 7,714,460 |
| 2017-03-10 | Denton David M (EVP and CFO) | Option Ex | 95,618 | 36.23 | 3,464,240 |
| 2017-02-16 | Roberts Jonathan C (EVP & President, CVS Caremark) | Sale | 61,196 | 80.00 | 4,895,680 |
| 2017-02-16 | Roberts Jonathan C (EVP & President, CVS Caremark) | Option Ex | 61,196 | 36.23 | 2,217,131 |
| 2017-02-01 | Merlo Larry J (President and CEO) | Sale | 76,494 | 78.32 | 5,991,010 |
| 2017-02-01 | Merlo Larry J (President and CEO) | Option Ex | 76,494 | 36.23 | 2,771,377 |
| 2016-05-05 | Brennan Troyen A (EVP and Chief Medical Officer) | Sale | 7,517 | 105.00 | 789,285 |
| 2016-05-05 | Gold Stephen J (EVP & CIO) | Sale | 9,798 | 105.00 | 1,028,790 |
| 2016-05-05 | Gold Stephen J (EVP & CIO) | Option Ex | 9,798 | 47.29 | 463,347 |
| 2016-04-01 | Sussman Andrew (EVP & Pres, CVS MinuteClinic) | Sale | 2,844 | 105.00 | 298,620 |
| 2016-04-01 | Gold Stephen J (EVP & CIO) | Sale | 21,922 | 105.00 | 2,301,810 |
| 2016-04-01 | Gold Stephen J (EVP & CIO) | Option Ex | 21,922 | 47.29 | 1,036,691 |
| 2016-03-09 | Brennan Troyen A (EVP, Chief Medical Officer) | Sale | 6,755 | 100.00 | 675,500 |
| 2016-03-09 | Merlo Larry J (President and CEO) | Sale | 38,247 | 100.00 | 3,824,700 |
| 2016-03-09 | Merlo Larry J (President and CEO) | Option Ex | 38,247 | 36.23 | 1,385,688 |
| 2016-02-01 | Merlo Larry J (President and CEO) | Sale | 46,393 | 96.14 | 4,459,991 |
| 2016-02-01 | Merlo Larry J (President and CEO) | Option Ex | 46,393 | 28.10 | 1,303,643 |
| 2016-01-11 | Merlo Larry J (President and CEO) | Sale | 46,393 | 95.00 | 4,407,335 |
| 2016-01-11 | Merlo Larry J (President and CEO) | Option Ex | 46,393 | 28.10 | 1,303,643 |
| 2016-01-04 | Finucane Anne A. (Director) | Sale | 2,000 | 95.88 | 191,750 |
| 2015-10-27 | Brennan Troyen A (EVP, Chief Medical Officer) | Sale | 23,603 | 105.00 | 2,478,315 |
| 2015-10-27 | Brennan Troyen A (EVP, Chief Medical Officer) | Option Ex | 23,603 | 54.53 | 1,287,071 |
| 2015-07-20 | Boratto Eva C (SVP, Cont & Chief Acct Officer) | Sale | 22,107 | 110.34 | 2,439,286 |
| 2015-07-20 | Boratto Eva C (SVP, Cont & Chief Acct Officer) | Option Ex | 22,107 | 30.16 | 666,747 |
| 2015-07-15 | Bisaccia Lisa (EVP, Chief HR Officer) | Sale | 49,908 | 110.00 | 5,489,979 |
| 2015-07-15 | Bisaccia Lisa (EVP, Chief HR Officer) | Option Ex | 41,982 | 52.68 | 2,211,443 |
| 2015-06-01 | Brown C David Ii (Director) | Sale | 10,000 | 102.57 | 1,025,699 |
| 2015-05-01 | Brown C David Ii (Director) | Sale | 15,000 | 100.27 | 1,504,050 |
| 2015-04-10 | Sussman Andrew (EVP & Pres, CVS/minuteclinic) | Sale | 17,638 | 102.38 | 1,805,831 |
| 2015-04-10 | Sussman Andrew (EVP & Pres, CVS/minuteclinic) | Option Ex | 12,556 | 49.80 | 625,288 |
| 2015-04-02 | Brennan Troyen A (EVP, Chief Medical Officer) | Sale | 16,637 | 102.71 | 1,708,786 |
| 2015-04-02 | Brennan Troyen A (EVP, Chief Medical Officer) | Option Ex | 16,637 | 45.07 | 749,829 |
| 2015-04-01 | Brennan Troyen A (EVP, Chief Medical Officer) | Sale | 16,747 | 102.26 | 1,712,548 |
| 2015-04-01 | Brennan Troyen A (EVP, Chief Medical Officer) | Option Ex | 16,747 | 34.96 | 585,475 |
| 2015-03-23 | Brennan Troyen A (EVP, Chief Medical Officer) | Sale | 33,274 | 104.94 | 3,491,773 |
| 2015-03-23 | Brennan Troyen A (EVP, Chief Medical Officer) | Option Ex | 33,274 | 45.07 | 1,499,659 |
| 2015-03-20 | Brown C David Ii (Director) | Sale | 25,000 | 104.30 | 2,607,500 |
| 2015-01-07 | Roberts Jonathan C (EVP & President, CVS/caremark) | Sale | 86,487 | 95.31 | 8,243,075 |
| 2015-01-07 | Roberts Jonathan C (EVP & President, CVS/caremark) | Option Ex | 86,487 | 41.17 | 3,560,669 |
| 2015-01-05 | Merlo Larry J (President and CEO) | Sale | 144,144 | 94.30 | 13,592,779 |
| 2015-01-05 | Merlo Larry J (President and CEO) | Option Ex | 144,144 | 41.17 | 5,934,408 |
| 2015-01-02 | Sussman Andrew (SVP & Pres, CVS/minuteclinic) | Sale | 4,220 | 95.67 | 403,714 |
| 2015-01-02 | Brennan Troyen A (EVP, Chief Medical Officer) | Sale | 50,240 | 95.71 | 4,808,520 |
| 2015-01-02 | Brennan Troyen A (EVP, Chief Medical Officer) | Option Ex | 50,240 | 34.96 | 1,756,390 |
| 2015-01-02 | Lofberg Per Gh (EVP) | Sale | 347,343 | 95.28 | 33,096,577 |
| 2015-01-02 | Lofberg Per Gh (EVP) | Option Ex | 347,343 | 45.07 | 15,654,749 |
Insider trading activities including stock purchases, stock sales, and option exercises of CVS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cvs Health Corp (symbol CVS, CIK number 64803) see the Securities and Exchange Commission (SEC) website.